HomeHealth

Health

Arena (ARNA) Starts Phase II Alopecia Areata Study on Etrasimod

Arena (ARNA) Starts Phase II Alopecia Areata Study on Etrasimod

September 2, 2020

Why Is Bruker (BRKR) Down 4.5% Since Last Earnings Report?

Why Is Bruker (BRKR) Down 4.5% Since Last Earnings Report?

September 2, 2020

Vertex Seeks Nod for Cystic Fibrosis Drugs for Rare Mutations

Vertex Seeks Nod for Cystic Fibrosis Drugs for Rare Mutations

September 2, 2020

Bristol Myers Gets FDA Approval for Oral AML Therapy Onureg

Bristol Myers Gets FDA Approval for Oral AML Therapy Onureg

September 2, 2020

AstraZeneca’s Imfinzi Gets EU Approval for First-Line SCLC

AstraZeneca’s Imfinzi Gets EU Approval for First-Line SCLC

September 2, 2020

Gilead Inks Deal With Jounce to License an Oncology Candidate

Gilead Inks Deal With Jounce to License an Oncology Candidate

September 2, 2020

Allogene Therapeutics Announces September 2020 Virtual Investor Conference Participation

Allogene Therapeutics Announces September 2020 Virtual Investor Conference Participation

September 2, 2020

Immunomedics to Participate in Upcoming Healthcare Conferences

Immunomedics to Participate in Upcoming Healthcare Conferences

September 2, 2020

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

September 2, 2020

argenx Management to Present at Upcoming Virtual Investor Conferences

argenx Management to Present at Upcoming Virtual Investor Conferences

September 2, 2020

« 1 … 857 858 859 860 861 … 942 »